Skip to main content

Industry Advocacy

  • Trump: ‘Drug industry getting away with murder’

    NEW YORK — President-elect Donald Trump took on health care and biotechnology companies during his Wednesday press conference.

    "We have to get our drug industry coming back. The drug industry has been disastrous, they're leaving left and right. They supply our drugs but they don't make them here, to a large extent," Trump said in the press conference. "And the other thing we have to do is create new bidding procedures for the drug industry because they're getting away with murder.”

  • PhRMA names Duato new board chairman

    WASHINGTON — The Pharmaceutical Research and Manufacturers of America have announced Monday that Joaquin Duato, Johnson & Johnson’s worldwide chairman, pharmaceuticals, would be succeeding George Scangos, the outgoing CEO of Biogen, as the organization’s board chairman. 
     
  • CRN joins IPA on industry guidelines for marketing probiotics

    WASHINGTON — The Council for Responsible Nutrition and the International Probiotics Association on Monday issued scientifically-based best-practice guidelines for the labeling, storing, and stability testing of dietary supplements and functional foods containing probiotics. As probiotics are quickly gaining popularity, the guidelines are designed to ensure probiotic manufacturers can consistently create high-quality products in which consumers can be confident.

  • Council for Responsible Nutrition relaunches website

    WASHINGTON, D.C. — The Council for Responsible Nutrition relaunched its website to enhance the user experience and simplify navigation.

  • CHPA abuse efforts working: DXM abuse holds at 3%

    WASHINGTON — The results of the 2016 National Institute on Drug Abuse and University of Michigan’s Monitoring the Future survey released earlier this week determined the percentage of teens using over-the-counter cough medicine containing dextromethorphan to get high remains at 3%.

    When first reported by Monitoring the Future in 2006, teen OTC cough medicine abuse was at just under 6%.

  • NPAC advocates separation of medical and recreational cannabis

    TORONTO  — The Neighbourhood Pharmacy Association of Canada on Tuesday applauded the federal government's Task Force on Marijuana Legalization and Regulation for recognizing the need to preserve the system of medical cannabis separate from the recreational system.

    In its report released yesterday, the Task Force clearly noted Neighbourhood Pharmacies' proposition that medical cannabis is a serious drug and that Canadians expect that strength and packaging standards applied to prescription medications be applied to cannabis.

  • VMS industry supports published AERs, but cautions to not take at face value

    WASHINGTON — The Council for Responsible Nutrition earlier this week embraced the Food and Drug Administration's decision to make public data from FDA’s Center for Food Safety and Applied Nutrition’s Adverse Event Reporting System, calling it a demonstration of the agency’s commitment to transparency.

X
This ad will auto-close in 10 seconds